Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer

Clinical trial NCT00245050 · COMPLETED

Trial details

NCT number: NCT00245050
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Drug/Agent Toxicity by Tissue/Organ Endometrial Cancer Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Cancer

Start date: 2004-04-01
Primary completion: 2008-04-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.